This study assessed the impact of ribavirin exposure on virologic relapse in combination therapy with pegylated interferon (Peg-IFN) and ribavirin for patients with chronic hepatitis C genotype 1.
Journal of Viral Hepatitis [ فقط المشتركين فى المنتدى يمكنهم رؤية الرابط . اضعط هنا للتسجيل ... ]
أ